Gilead Sciences
Headlines
U.S. Gains COVID-19 Drug Monopoly for Gilead’s 31,900% Markup
July 1, 2020
Headlines Opinion
Gilead Sciences Stock Is Rallying – And the Reason Why May Sicken You
June 29, 2020
Headlines Opinion
The Stock Market Is Insane to Rally on Gilead’s Flimsy Remdesivir Study
April 29, 2020
Headlines Opinion
Why Your Favorite ‘Coronavirus Stock’ Just Took Wall Street on a Nasty Ride
April 23, 2020
Markets News & Opinions
Dow Swings Wildly After Trial ‘Flop’ Ignites Coronavirus Drug Fears
April 23, 2020
Markets News & Opinions
This Is Why the Dow Jones Soared While Its 2 Biggest Stocks Dove
April 17, 2020
Headlines Opinion
Why It’s Too Early to Celebrate Gilead Sciences’ Coronavirus Therapy
April 17, 2020
By using CCN.com you consent to our
privacy & cookie policy.
Continue